Susquehanna International Group
PRAH

Susquehanna International Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Susquehanna International Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,300
Closed -$1.04M – 14139
2021
Q2 		$1.04M Sell
6,300
-2,800
-31% -$467K ﹤0.01% 7656
2021
Q1 		$1.4M Buy
9,100
+5,800
+176% +$788K ﹤0.01% 6850
2020
Q4 		$414K Sell
3,300
-2,500
-43% -$280K ﹤0.01% 8672
2020
Q3 		$588K Sell
5,800
-6,300
-52% -$642K ﹤0.01% 7334
2020
Q2 		$1.18M Sell
12,100
-14,900
-55% -$1.39M ﹤0.01% 5556
2020
Q1 		$2.24M Buy
27,000
+6,600
+32% +$644K ﹤0.01% 3773
2019
Q4 		$2.27M Sell
20,400
-27,200
-57% -$2.8M ﹤0.01% 4112
2019
Q3 		$4.72M Sell
47,600
-12,500
-21% -$1.24M ﹤0.01% 2808
2019
Q2 		$5.96M Sell
60,100
-41,200
-41% -$3.93M ﹤0.01% 2478
2019
Q1 		$11.2M Buy
101,300
+52,800
+109% +$5.52M ﹤0.01% 1640
2018
Q4 		$4.46M Sell
48,500
-6,500
-12% -$658K ﹤0.01% 2415
2018
Q3 		$6.06M Buy
55,000
+23,100
+72% +$2.41M ﹤0.01% 2450
2018
Q2 		$2.98M Buy
31,900
+17,700
+125% +$1.52M ﹤0.01% 3392
2018
Q1 		$1.18M Buy
14,200
+2,300
+19% +$204K ﹤0.01% 4913
2017
Q4 		$1.08M Sell
11,900
-10,200
-46% -$848K ﹤0.01% 5065
2017
Q3 		$1.68M Sell
22,100
-4,200
-16% -$317K ﹤0.01% 4230
2017
Q2 		$1.97M Buy
26,300
+13,400
+104% +$929K ﹤0.01% 3929
2017
Q1 		$841K Sell
12,900
-10,900
-46% -$642K ﹤0.01% 5493
2016
Q4 		$1.31M Buy
23,800
+7,600
+47% +$417K ﹤0.01% 4953
2016
Q3 		$915K Sell
16,200
-3,200
-16% -$157K ﹤0.01% 4970
2016
Q2 		$810K Buy
+19,400
New +$894K ﹤0.01% 5266
2016
Q1 		– Sell
-9,100
Closed -$412K – 9925
2015
Q4 		$412K Buy
9,100
+1,400
+18% +$58.8K ﹤0.01% 7133
2015
Q3 		$299K Buy
7,700
+700
+10% +$28K ﹤0.01% 8045
2015
Q2 		$254K Buy
+7,000
New +$221K ﹤0.01% 8849

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Susquehanna International Group's PRAH Position: Q3 2021 in Review

Susquehanna International Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 622,837 shares — an estimated $103M sold.

Susquehanna International Group first reported a position in PRAH in Q4 2014 and held it in 18 quarters. The position peaked at $103M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Susquehanna International Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Susquehanna International Group sold 622,837 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $103M.
  • Susquehanna International Group first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 18 quarters.
  • Susquehanna International Group's PRA Health Sciences, Inc. position peaked at $103M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.